# Altering Lipids for Tolerance of Aromatase Inhibitor Therapy

> **NCT04268134** · PHASE2 · COMPLETED · sponsor: **University of Michigan Rogel Cancer Center** · enrollment: 77 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** Omega-3 fatty acid supplement

## Key facts

- **NCT ID:** NCT04268134
- **Lead sponsor:** University of Michigan Rogel Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-28
- **Primary completion:** 2024-02-27
- **Final completion:** 2024-02-27
- **Target enrollment:** 77 (ACTUAL)
- **Last updated:** 2026-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04268134

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04268134, "Altering Lipids for Tolerance of Aromatase Inhibitor Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04268134. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*